• Home
  • History
    • Introduction
    • The Aspirin Story
    • Timeline
    • Chemistry
  • Advisory Board
  • Awards
  • Conferences
  • Scientific Information
    • Guidelines
    • Disease Prevention
    • Aspirin Summaries
    • Aspirin Matters
  • News
  • Contact
Menu
  • Home
  • History
    • Introduction
    • The Aspirin Story
    • Timeline
    • Chemistry
  • Advisory Board
  • Awards
  • Conferences
  • Scientific Information
    • Guidelines
    • Disease Prevention
    • Aspirin Summaries
    • Aspirin Matters
  • News
  • Contact
Search
Close

Conferences

Our biennial conference is a great opportunity to hear from leading biomedical researchers across a range of specialties.  By coming together discuss the latest international data, we can enhance understanding, build stronger networks and inspire new ideas.

  • 2022 Scientific Conference
  • – Conference Speakers
  • 2021 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2019 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2018 Scientific Conference
  • – Conference Speakers
  • 2017 : ASPIRIN: 120 Years of Innovation
  • – Conference Speakers
  • 2015 : ASPIRIN In The 21ST Century
  • – Conference Speakers
  • – Conference Videos
  • 2022 Scientific Conference
  • – Conference Speakers
  • 2021 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2019 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2018 Scientific Conference
  • – Conference Speakers
  • 2017 : ASPIRIN: 120 Years of Innovation
  • – Conference Speakers
  • 2015 : ASPIRIN In The 21ST Century
  • – Conference Speakers
  • – Conference Videos
Menu
  • 2022 Scientific Conference
  • – Conference Speakers
  • 2021 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2019 Scientific Conference
  • – Conference Speakers
  • – Conference Videos
  • 2018 Scientific Conference
  • – Conference Speakers
  • 2017 : ASPIRIN: 120 Years of Innovation
  • – Conference Speakers
  • 2015 : ASPIRIN In The 21ST Century
  • – Conference Speakers
  • – Conference Videos

2022 Conference Speakers

The International Aspirin Foundation Scientific Conference 2021 is attracting worldwide speakers.

Session One :

2022 04 12 11 38 06 Window

Dr Jean-Philippe Collet is a Professor of Cardiology at Pitié-Salpêtrière Hospital (APHP) where he leads the interventional catheterization unit (PCI and TAVI). He is also the director of Cardiovascular Training Program at Sorbonne Université. His main expertise is in the field of thrombosis, the effect of antithrombotic agents and the development of new devices for structural heart intervention.

Full Biography

Professor J Michael Gaziano is the Principal Investigator, Million Veteran Program and Executive Director of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Heathcare System; Chief, Division of Aging, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School; all in Boston, Massachusetts, USA.

Full biography

Gaziano
Ge

Professor Junbo Ge FESC, FACC, FAHA, obtained his medical degree from the University of Mainz in Germany in 1993 and now an Academician of The Chinese Academy of Sciences and the Yangtze River Scholar. He is the President of the Chinese College of Cardiovascular Physicians and the President of Chinese Cardiovascular Health Alliance, Anhui Provincial Hospital.

Full biography 

Professor Carlo Patrono’s main research interest is in the study of platelet activation and inhibition in atherothrombosis and colorectal cancer. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet COX-1 and provided the basis for the development of low-dose aspirin as an antithrombotic agent.

Full biography

CarloPatrono
Bianca Rocca

Bianca Rocca, MD, PhD is Associate Professor of Pharmacology at the Catholic University School of Medicine in Rome (Italy) and achieved the National Scientific Qualification for Full Professor of Pharmacology. 

Her main scientific interests are antithrombotic drugs, eicosanoids, haemostasis, platelets, non-steroidal anti-inflammatory drugs, cardiovascular diseases.

Full Biography 

Professor Gemma Vilahur is Group Leader at the Research Institute of the Hospital de la Santa Creu i Sant Pau (Barcelona). She has published 160 articles (H=41; >5400 citations) including original manuscripts, consensus and position papers, and reviews. She is and has been principal investigator and co-investigator of multiple research projects (National and European projects either funded by public agencies or industry).

Full Biography

Gemma Vilahur

Session Two:

Pierre A Web Photo 2

Professor Pierre Amarenco is a Professor of Neurology at Paris University and Chairman of the Department of Neurology and Stroke Center at Bichat University Hospital

Full Biography

Professor Matthias Endres is Chair of Neurology at the Charité Hospital in Berlin. Together with Ulrich Dirnagl he is also the founding Director of the Center for Stroke Research Berlin. His major research interests are preventive vascular mechanisms, mechanisms of cell death, regeneration and functional outcome, heart-brain interaction, post-stroke depression, and telemedicine. 

Full biography

Endres Cropped
Rothwell

Professor Peter Rothwell is a clinical neurologist with interests in stroke, vascular dementia, hypertension and aspirin.  As an MRC Senior Clinical Fellow he established the Stroke Prevention Research Unit in Oxford in 2000, which was awarded the Queen’s Anniversary Prize for Higher and Further Education in 2014. He subsequently founded the purpose-built Wolfson Centre for Prevention of Stroke and Dementia, which opened in 2020. 

Full biography

Professor Lawrence Wong is a neurologist who uses advanced imaging technologies to further our understanding of stroke in Asia. Stroke is one of the leading causes of death and disability worldwide. 20 years ago, Wong observed that stroke was more prevalent among Asians than Caucasians. However, research into this area was lacking. He began to use Transcranial Doppler, an ultrasound imaging technology, to look at blood flow in brain blood vessels. 

Full biography

Dr Wong Ka Sing Lawrence S Updated
Kasner Scott Whitecoat Print

Dr. Scott E. Kasner earned his B.S. in Physics and Zoology from Duke University, M.D. from Yale University, and a Master’s of Science in Clinical Epidemiology (M.S.C.E.) from the University of Pennsylvania. He trained in Neurology at the University of Pennsylvania, and then in Stroke and Neurocritical Care at the University of Texas at Houston. 

Full biography

Session Three:

Gastro Head Shots And Group

Professor Andrew T. Chan, MD, MPH is a gastroenterologist, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School, Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health, Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital and the Director of Epidemiology at the MGH Cancer Center.  Dr. Chan is an international expert in cancer prevention and interception, leading several seminal studies examining the role of aspirin, diet, and the gut microbiome on cancer risk.

Full Biography.

Dr C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Mumbai. He serves on the UICC Board of Directors. He is the convener for the National Cancer Grid, a large network of 266 cancer centres in India (https://tmc.gov.in/ncg). The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country.

Full Biography

Dr C S Pramesh, Ms, Frcs, Director Of The Tata Memorial Hospital In Mumbai, India
Chia

Dr John Chia is a clinical oncologist, the former Chief of the Gynaecology Oncology service in the Division of Medical Oncology, National Cancer Centre, and is a founding board member of the Gynecologic Cancer Group Singapore, and the chair of its scientific sub-committee.

Full biography

Professor Ruth Langley is a Medical Oncologist specialising in the design and management of oncology clinical trials based at the MRC Clinical Trials Unit at University College London where she leads the Cancer Group.  She has worked in a number of tumour areas including colorectal, lung and gastro-oesophageal cancer coordinating a series of trials and associated translational studies. 

Full biography

Langley
Anna Martling

Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003, became a board certified surgeon in 2004 and an associate professor of surgery in 2009. In 2014 Martling became full professor of surgery. Since 2019 she hold the position as Dean at Karolinska Institutet, Stockholm.

Full biography

Session Four :

Badimon

Professor Lina Badimon is the Director of the Cardiovascular Science Program (ICCC) at the Hospital Santa Creu and San Pau, Director of the Cardiovascular Research Chair of the Autonomous University of Barcelona, Professor at the National Research Council of Spain (CSIC),  and Director of the UNESCO Chair in Biomedical Sciences Training and Research. She is Visiting Professor of Manchester Metropolitan University (UK) and University-Paris-East (FR).

Full biography

Dr Emmanuel Bujold is a full professor at the Department of Obstetrics & Gynaecology of Laval University’s School of Medicine where he holds the Jeanne et Jean-Louis Lévesque Research Chair in Perinatology.

Full biography

Bujolde1
Gastro Head Shots And Group

Professor Andrew T. Chan, MD, MPH is a gastroenterologist, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School, Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health, Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital and the Director of Epidemiology at the MGH Cancer Center.  Dr. Chan is an international expert in cancer prevention and interception, leading several seminal studies examining the role of aspirin, diet, and the gut microbiome on cancer risk.

Full biography

Professor Marc Hochbert is a professor of Medicine and Epidemiology and Public Health Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine Director, Medical Care Clinical Center VA Maryland Health Care System.

Full biography

Hochberg Marc
Elisa L 2020 2

Dr Elisa Llurba, MD, PhD (ELL) is the Head of Obstetrics and Gynecology Department at the Santa Creu i Sant Pau University Hospital. Associated Professor in Medicine of the Autonomous University of Barcelona (UAB) and principal investigator (PI) of the Perinatal and Women’s Health Group, in the Santa Creu and Sant Pau Hospital Research Institute in Barcelona. Coordinate’s work of 15 pre-doctoral researchers and 3 post- doctoral investigators. 

Full biography

Professor Carlo Patrono’s main research interest is in the study of platelet activation and inhibition in atherothrombosis and colorectal cancer. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet COX-1 and provided the basis for the development of low-dose aspirin as an antithrombotic agent.

Full biography

CarloPatrono
Luis Alberto García Rodríguez Picture

Dr Luis A. García Rodríguez obtained his medical degree at the University of Alicante in 1984, his MPH degree at the Free University of Brussels in 1986 and his MSc degree in Epidemiology at the Harvard School of Public Health in 1988. From that date, his career has been dedicated to epidemiologic evaluation of drug safety and effectiveness: pharmacoepidemiologic research.

Full biography

Professor Zhu Chen is Professor of Medicine, Chief Physician, Department of Rheumatology and Immunology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China.

Full biography

Zhu Chen

Connect with us

Sign up to be part of the aspirin community and be the first to receive latest information.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Have something to say about aspirin?

Contact Us Here
Footer Logo
  • Terms & Conditions
  • Branding Guidelines
  • Privacy
  • Cookie Policy
  • Disclaimer
  • Terms & Conditions
  • Branding Guidelines
  • Privacy
  • Cookie Policy
  • Disclaimer
TwitterLinkedin

Copyright © 2020 Aspirin Foundation

Website by mtc.

Have something to say about aspirin?

Please fill in the form below and we will contact you with further information.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Djp

Daniel José Piñeiro

ASSOCIATE
Name
Daniel José Piñeiro
Academic Affiliations:
Full Professor of Medicine, Universidad de Buenos Aires, Argentina Trustee, Board of Trustees, American College of Cardiology
Professional Setting:
My academic experience includes more than 40 years as a practicing medical doctor, teacher, and researcher. I have fulfilled these appointments in settings of vital social engagement and impact, most notably at the Hospital de Clínicas “José de San Martín” of the Universidad de Buenos Aires, a public hospital with high academic recognition. Additionally, I currently hold the position of Full Professor of Medicine at that same University.
Academic Activities:
  • International Meetings Participations: 180
  • Books-Editor: 1
  • Books Chapters: 39
  • Refereed Full Articles: 118 (listed in Pubmed: 29)
  • Refereed Abstracts: 221
  • Editorial Boards: 10
Profesional Associations:
  • 2005 President, Sociedad Argentina de Cardiología.
  • 2011-2013 President, Inter-American Society of Cardiology.
  • 2011-2013 Member (ex-officio), Board of Directors, World Heart Federation
  • 2017-2018 Member (at large), Board of Directors, World Heart Federation
  • 2018-2021 Trustee, Board of Trustees, American College of Cardiology
Return to Scientific Advisory Board
Chia

John Chia

Name
John Chia MBBS (Spore), MRCP (UK), FAMS (Spore)
Academic Affiliations:

Adjunct Associate Professor DUKE-NUS Graduate Medical School,
Consultant Oncologist Curie Oncology Singapore,
Visiting Consultant National Cancer Centre Singapore.

Discipline:

Medical Oncology

Scientific Interests:
  • Aspirin as adjuvant therapy in established cancers
  • Adoptive T cell therapy and Dendritic cell vaccines in the treatment of solid tumors
  • Clinical Trial Design and Management
Declaration of Conflicts of Interest:

In the past 3 years, I have received consultant fees from Tessa Therapeutics, Aslan Pharmaceuticals, Novartis, and AstraZeneca.

I received grant support for investigator-initiated research from:

  • National Medical Research Council Singapore
  • Bayer AG

I hold shares in:  Roche, BMS, AstraZeneca, Incyte, Teva Pharmaceuticals, Trillium Therapeutics, Compugen, Arrowhead pharmaceuticals, Emergex, QuantumDx and Halozyme Therapeutics

Return to Scientific Advisory Board
Badimon

Lina Badimon

Name
Lina Badimon BSc, PharmD, PhD, FESC, FAHA
Academic Affiliations:
Director of the Cardiovascular Science Program (ICCC) at the Hospital Santa Creu and San Pau, IIB-Sant Pau; CIBER CV. Director of the Cardiovascular Research Chair of the Autonomous University of Barcelona and Director of the UNESCO Chair in Biomedical Sciences Training and Research.
Discipline:
Pharmacology, Cardiovascular Disease
Scientific Interests:
Cardio-metabolic diseases, thrombosis, atherosclerosis and ischemic heart disease
Declaration of Conflicts of Interest:

I received consultant and speakers fees from Amgen, AstraZeneca, Bayer, Lilly and Sanofi.

    Return to Scientific Advisory Board
    Ge

    Junbo Ge

    Name

    Junbo Ge

    Ge Junbo, male, was born in Wulian, Shandong province on Nov. 8, 1962. He is the member of Chinese Academy of Sciences, professor and doctoral supervisor. He received his doctor’s degree of Medicine from German Mayence University in 1993 and now works as the director for Shanghai Institute of Cardiovascular Disease and the Center for Stem Cells and Tissue Engineering, Fudan University. He is also the designate chairman of the Cardiovascular Disease Branch of Chinese Medical Association, council member of the Cardiovascular Angiography and Interventions Association, international consultant of the American Heart Association. In Dec. 2013, he was appointed as the vice president of Tongji University.

    Prof. Ge has been engaged in clinical and scientific research work of cardiovascular disease since 1987, and his research area covers the pathogenesis of coronary heart disease, early diagnosis and treatment plan optimization.

    Return to Scientific Advisory Board
    Langley

    Ruth Langley

    Name
    Ruth Langley PhD, FRCP
    Academic Affiliations:
    Professor of Oncology and Clinical Trials, MRC Programme Leader and Chair of the Cancer Group, MRC Clinical Trials Unit at UCL, honorary consultant in medical oncology at the Brighton and Sussex University Hospital.
    Discipline:
    Medical oncologist; trialist
    Scientific Interests:
    • Aspirin
    • Gastro-oesophageal malignancy
    • Transdermal oestrogen in the treatment of prostate cancer
    • Trials methodology
    Declaration of Conflicts of Interest:
    Has received honorarium from Bayer
    Return to Scientific Advisory Board
    Chan

    Andrew T Chan

    Name
    Andrew T. Chan MD, MPH
    Academic Affiliations:
    Chief, Clinical and Translational Epidemiology Unit, Vice Chair, Division of Gastroenterology, Massachusetts General Hospital, Boston, Co-leader, Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, Boston.
    Discipline:
    Gastroenterology
    Scientific Interests:
    • The role of aspirin in the prevention of colorectal cancer and other cancers
    • The role of the gut microbiome in colorectal cancer and other chronic gastrointestinal diseases, including inflammatory bowel disease and diverticulitis
    • The role of diet and lifestyle in colorectal cancer and other chronic gastrointestinal cancers
    Declaration of Conflicts of Interest:

    AACR Honors Dr. Andrew T. Chan With 2019 AACR-Waun Ki Hong Award

    Click here to find the press release.

    I received consultant Bayer and Pfizer, Inc.

    I received grant support for investigator-initiated research from:

    • National Institutes of Health
    • National Cancer Institute
    • Crohn’s and Colitis Foundation
    • Bayer AG
    Return to Scientific Advisory Board
    Gaziano

    Mike Gaziano

    Name
    J Michael Gaziano MD, MPH
    Academic Affiliations:

    Professor of Medicine, Harvard Medical School; Chief Division of Aging, Brigham and Women’s Hospital; Director of Preventive Cardiology and Director of Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System.
    Discipline: Cardiology and Epidemiology

    Scientific Interests:
    I am a chronic disease epidemiologist with a particular interest in the roles that individual lifestyle choices (diet, exercise, smoking), metabolic factors (obesity, high cholesterol, and hypertension), and biochemical and genetic markers play on the risk of cardiovascular disease and other chronic illnesses. Also, of interest is the impact that vascular disease has on other organ systems, including cognitive dysfunction and renal disease. I have an interest in the design of large-scale trials and observational studies nested in large health care systems using big data analytic techniques.
    Declaration of Conflicts of Interest:

    I received consultant and speaker fees Bayer.

    I received grant support as a principal investigator or co-investigator for research from the VA, DOD, NIH, Merck and Kowa.

    Return to Scientific Advisory Board
    Pierre A Web Photo

    Pierre Amarenco

    Name

    Pierre Amarenco, MD, FAHA, FAAN

    Academic Affiliations:
    • Professor of Neurology at Paris-Diderot Sorbonne University 
    • Chairman of the Department of Neurology and Stroke Center; Bichat University Hospital
    • Co-Director INSERM Unit-698 “Clinical Research in Atherothrombosis”
    Discipline:

    Neurology and Vascular Neurology

    Scientific Interests:
    • Understanding and preventing stroke and vascular diseases
    • Clinical trials in prevention of vascular diseases
    • Carotid intima-media thickness studies
    • Lipid trials: prevention and therapeutic –protective- evaluation
    Declaration of Conflicts of Interest:

    N/A

    Return to Scientific Advisory Board
    CarloPatrono

    Carlo Patrono

    CHAIR
    Name
    Carlo Patrono MD, FESC, FRCP
    Academic Affiliations:
    Adjunct Professor of Pharmacology at the Catholic University School of Medicine in Rome (Italy) and at the Perelman School of Medicine of the University of Pennsylvania in Philadelphia (USA).
    Discipline:
    Clinical Pharmacology
    Scientific Interests:
    • Studying platelet activation and inhibition in diabetes mellitus
    • Studying platelet activation and inhibition in myeloproliferative neoplasms
    • Investigating the mechanism of action of low-dose aspirin in preventing colorectal cancer
    Declaration of Conflicts of Interest:

    I received consultant and speakers fees from Acticor Biotech,  Amgen,  Bayer, GlaxoSmithKline,  Tremeau,  Zambon.

    I received grant support for investigator-initiated research from:

    • AIFA (Italian Drug Agency)
    • Bayer AG
    • Cancer Research UK
    • European Commission, FP6 and FP7 Programmes

      Return to Scientific Advisory Board

      Have something to say about aspirin?

      We would like to hear from you and have a chat, and maybe feature you on our podcast. Please fill in the form below and we will contact you with further information.

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.